| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 935-941, Copyright © 1989 by Endocrine Society
ARTICLES |
R Kremer, I Bolivar, D Goltzman and GN Hendy
Department of Medicine, McGill University Montreal, Quebec, Canada.
Exposure of quiescent bovine parathyroid cells to serum or a serum substitute caused an elevation in [3H] thymidine incorporation, followed by an increase in cell number. This was preceded by a rapid transient rise in c-myc and c-fos proto-oncogene mRNA levels. Alterations in the medium calcium concentration had no effect on the growth state of quiescent parathyroid cells. In addition, varying the medium calcium concentration did not influence either the time course or the degree of induction of proto-oncogene expression or the subsequent increase in [3H] thymidine uptake or proliferation of stimulated parathyroid cells. In contrast, when 1,25- dihydroxycholecalciferol was added with serum or serum substitute to quiescent parathyroid cells, no increase in c-myc mRNA levels was observed, and the expected increase in parathyroid cell number failed to occur. The augmentation in c-fos mRNA in response to serum was not, however, altered by 1,25-dihydroxycholecalciferol. These results indicate that 1,25-dihydroxyvitamin D, but not extracellular calcium, may directly modulate parathyroid cell proliferation by altering the expression of specific replication-associated oncogenes.
This article has been cited by other articles:
 |
|
 |
|
  T. Drueke, D. Martin, and M. Rodriguez Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1828 - 1839. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zajickova, J. Vrbikova, L. Canaff, P. D. Pawelek, D. Goltzman, and G. N. Hendy Identification and Functional Characterization of a Novel Mutation in the Calcium-Sensing Receptor Gene in Familial Hypocalciuric Hypercalcemia: Modulation of Clinical Severity by Vitamin D Status J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2616 - 2623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Martin and E. A. Gonzalez Metabolic Bone Disease in Chronic Kidney Disease J. Am. Soc. Nephrol., March 1, 2007; 18(3): 875 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bjorklund, G. Akerstrom, and G. Westin Accumulation of Nonphosphorylated {beta}-Catenin and c-myc in Primary and Uremic Secondary Hyperparathyroid Tumors J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 338 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Samander and A. Arnold Mutational Analysis of the Vitamin D Receptor Does Not Support Its Candidacy as a Tumor Suppressor Gene in Parathyroid Adenomas J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5019 - 5021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Martin, C. S. Ritter, E. Slatopolsky, and A. J. Brown Acute regulation of parathyroid hormone by dietary phosphate Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E729 - E734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Larsson, R. Marsell, E. Schipani, C. Ohlsson, O. Ljunggren, H. S. Tenenhouse, H. Juppner, and K. B. Jonsson Transgenic Mice Expressing Fibroblast Growth Factor 23 under the Control of the {alpha}1(I) Collagen Promoter Exhibit Growth Retardation, Osteomalacia, and Disturbed Phosphate Homeostasis Endocrinology, July 1, 2004; 145(7): 3087 - 3094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Panda, D. Miao, I. Bolivar, J. Li, R. Huo, G. N. Hendy, and D. Goltzman Inactivation of the 25-Hydroxyvitamin D 1{alpha}-Hydroxylase and Vitamin D Receptor Demonstrates Independent and Interdependent Effects of Calcium and Vitamin D on Skeletal and Mineral Homeostasis J. Biol. Chem., April 16, 2004; 279(16): 16754 - 16766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kifor, I. Kifor, F. D. Moore Jr., R. R. Butters Jr., T. Cantor, P. Gao, and E. M. Brown Decreased Expression of Caveolin-1 and Altered Regulation of Mitogen-Activated Protein Kinase in Cultured Bovine Parathyroid Cells and Human Parathyroid Adenomas J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4455 - 4464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tokumoto, K. Tsuruya, K. Fukuda, H. Kanai, S. Kuroki, H. Hirakata, and M. Iida Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27 Nephrol. Dial. Transplant., March 1, 2003; 18(90003): iii9 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wada and N. Nagano Control of parathyroid cell growth by calcimimetics Nephrol. Dial. Transplant., March 1, 2003; 18(90003): iii13 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Cordero, M. Cozzolino, Y. Lu, M. Vidal, E. Slatopolsky, P. D. Stahl, M. A. Barbieri, and A. Dusso 1,25-Dihydroxyvitamin D Down-regulates Cell Membrane Growth- and Nuclear Growth-promoting Signals by the Epidermal Growth Factor Receptor J. Biol. Chem., October 4, 2002; 277(41): 38965 - 38971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Shattuck, J. Costa, M. Bernstein, R. T. Jensen, D. C. Chung, and A. Arnold Mutational Analysis of Smad3, a Candidate Tumor Suppressor Implicated in TGF-{beta} and Menin Pathways, in Parathyroid Adenomas and Enteropancreatic Endocrine Tumors J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3911 - 3914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Halloran, P. Uden, Q.-Y. Duh, S. Kikuchi, T. Wieder, J. Cao, and O. Clark Parathyroid gland volume increases with postmaturational aging in the rat Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E557 - E563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jara, S. Gonzalez, A. J. Felsenfeld, C. Chacon, A. Valdivieso, R. Jalil, and B. Chuaqui Failure of high doses of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats Nephrol. Dial. Transplant., March 1, 2001; 16(3): 506 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kanesaka, H. Tokunaga, K. Iwashita, S. Fujimura, S. Naomi, and K. Tomita Endothelin Receptor Antagonist Prevents Parathyroid Cell Proliferation of Low Calcium Diet-Induced Hyperparathyroidism in Rats Endocrinology, January 1, 2001; 142(1): 407 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Brown and R. J. MacLeod Extracellular Calcium Sensing and Extracellular Calcium Signaling Physiol Rev, January 1, 2001; 81(1): 239 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. CANALEJO, Y. ALMADÉN, V. TORREGROSA, J. C. GOMEZ-VILLAMANDOS, B. RAMOS, J. M. CAMPISTOL, A. J. FELSENFELD, and M. RODRÍGUEZ The In Vitro Effect of Calcitriol on Parathyroid Cell Proliferation and Apoptosis J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1865 - 1872. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. El Abdaimi, N. Dion, V. Papavasiliou, P.-E. Cardinal, L. Binderup, D. Goltzman, L.-G. Ste-Marie, and R. Kremer The Vitamin D Analogue EB 1089 Prevents Skeletal Metastasis and Prolongs Survival Time in Nude Mice Transplanted with Human Breast Cancer Cells Cancer Res., August 1, 2000; 60(16): 4412 - 4418. [Abstract] [Full Text]
|
|
|
|
|
|
T. B. DRÜEKE Cell Biology of Parathyroid Gland Hyperplasia in Chronic Renal Failure J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1141 - 1152. [Full Text]
|
|
|
|
|
|
T. Carling, J. Rastad, E. Szabó, G. Westin, and G. Åkerström Reduced Parathyroid Vitamin D Receptor Messenger Ribonucleic Acid Levels in Primary and Secondary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2000 - 2003. [Abstract] [Full Text]
|
|
|
|
|
|
N. J. Schroeder and J. Cunningham What's new in vitamin D for the nephrologist? Nephrol. Dial. Transplant., April 1, 2000; 15(4): 460 - 466. [Full Text] [PDF]
|
|
|
|
|
|
L. Canaff, H. P. J. Bennett, Y. Hou, N. G. Seidah, and G. N. Hendy Proparathyroid Hormone Processing by the Proprotein Convertase-7: Comparison with Furin and Assessment of Modulation of Parathyroid Convertase Messenger Ribonucleic Acid Levels by Calcium and 1,25-Dihydroxyvitamin D3 Endocrinology, August 1, 1999; 140(8): 3633 - 3642. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Nyska, J. K. Haseman, J. R. Hailey, S. Smetana, and R. R. Maronpot The Association Between Severe Nephropathy and Pheochromocytoma in the Male F344 Rat-- The National Toxicology Program Experience Toxicol Pathol, July 1, 1999; 27(4): 456 - 462. [Abstract] [PDF]
|
|
|
|
|
|
K. E. Abdaimi, V. Papavasiliou, S. A. Rabbani, J. S. Rhim, D. Goltzman, and R. Kremer Reversal of Hypercalcemia with the Vitamin D Analogue EB1089 in a Human Model of Squamous Cancer Cancer Res., July 1, 1999; 59(14): 3325 - 3328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Carling, J. Rastad, G. Åkerström, and G. Westin Vitamin D Receptor (VDR) and Parathyroid Hormone Messenger Ribonucleic Acid Levels Correspond to Polymorphic VDR Alleles in Human Parathyroid Tumors J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2255 - 2259. [Abstract] [Full Text]
|
|
|
|
|
|
T. Carling, P. Ridefelt, P. Hellman, J. Rastad, and G. Akerstrom Vitamin D Receptor Polymorphisms Correlate to Parathyroid Cell Function in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1772 - 1775. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
